Epiomic Epidemiology Series: Cerebral Palsy Forecast in 8 Major Markets 2015-2025

November 2015 | 48 pages | ID: EFF3AA6DE02EN
Black Swan Analysis limited

Abstracts

Cerebral Palsy lacks a precise definition as it is not a single disease, but an umbrella term describing non-progressive brain lesions involving motor or postural abnormalities that are noted in early development. The exact pathological mechanisms and processes that cause Cerebral Palsy are largely unknown. However, premature birth, exposure to infection or radiation during pregnancy and post-natal head injuries are all associated risk factors in developing Cerebral Palsy.

This report provides the current prevalent population for Cerebral Palsy across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Cerebral Palsy have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Cerebral Palsy include:

• Low weight at birth
• Premature birth (pre-term)
• Epilepsy and seizures
• Sensory impairment
• Congenital malformations

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Cerebral Palsy’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Cerebral Palsy and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Cerebral Palsy’s prevalent population.
• Identify sub-populations within Cerebral Palsy which require treatment.
• Gain an understanding of the specific markets that have the largest number of Cerebral Palsy patients.

Contents

Introduction
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions /Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Prevalence for Cerebral Palsy
Main Features of Cerebral Palsy
  Type of Motor Symptoms
  Cerebral Palsy by topographic type
  GMFCS Level in Cerebral Palsy Patients
  BFMF Level in Cerebral Palsy Patients
  Timing of onset of Cerebral Palsy
  Cause of post-natal Cerebral Palsy
  Gestational age at time of birth
  Walk ability in patients with Cerebral Palsy
  Neurological Comorbidites in Cerebral Palsy Patients
  Intellectual Deficit in Cerebral Palsy
  Sensory deficits in Cerebral Palsy Patients
  Orthopaedic Impairments
  Congenital malformations in patients with Cerebral Palsy
Abbreviations and Acronyms used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix

List Of Tables

LIST OF TABLES

Classification systems used to describe cerebral palsy
Prevalence of Cerebral Palsy, total (000s)
Prevalence of Cerebral Palsy, males (000s)
Prevalence of Cerebral Palsy, females (000s)
Type of motor symptoms in Cerebral Palsy patients, total (000s)
Topography type of Cerebral Palsy patients, total (000s)
GMFCS level in Cerebral Palsy patients, total (000s)
BFMF level in Cerebral Palsy patients, total (000s)
Cerebral Palsy patients with severely impaired upper limb function, total (000s)
Cerebral Palsy patients with difficulties feeding by mouth, total (000s)
Timing of onset of Cerebral Palsy, total (000s)
Cause of Cerebral Palsy in post-natal patients, total (000s)
Cerebral Palsy caused by meningitis or encephalitis, total (000s)
Gestational age at time of birth for Cerebral Palsy patients, total (000s)
Walking ability of Cerebral Palsy patients, total (000s)
Epilepsy in Cerebral Palsy patients, total (000s)
Active seizure in Cerebral Palsy patients, total (000s)
Severe intellectual deficit in Cerebral Palsy patients, IQ < 50, total (000s)
Intellectual deficit in Cerebral Palsy patients, IQ 50-70, total (000s)
Visual impairment in Cerebral Palsy patients, total (000s)
Severe visual impairment in Cerebral Palsy patients, total (000s)
Hearing loss in Cerebral Palsy patients, total (000s)
Severe hearing loss in Cerebral Palsy patients, total (000s)
Hip sub-dislocation in Cerebral Palsy patients, total (000s)
Equinus in Cerebral Palsy patients, total (000s)
Scoliosis in Cerebral Palsy patients, total (000s)
Number of Cerebral Palsy patients with congenital malformations, total (000s)
Number of Cerebral Palsy patients with cerebral malformations, total (000s)
Number of Cerebral Palsy patients with congenital heart disease, total (000s)
Number of Cerebral Palsy patients with gastrointestinal malformations, total (000s)
Number of Cerebral Palsy patients with genitourinary malformations, total (000s)
Abbreviations and acronyms used in the report
USA Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
USA Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
France Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
France Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
Germany Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
Germany Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
Italy Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
Italy Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
Spain Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
Spain Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
United Kingdom Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
United Kingdom Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
Brazil Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
Brazil Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)
Japan Prevalence of Cerebral Palsy by 5-yr age cohort, males (000s)
Japan Prevalence of Cerebral Palsy by 5-yr age cohort, females (000s)